Palivizumab serumkoncentrationer på cirka 30 μg/ ml er vist at medføre en 99% reduktion i pulmonal RSV replikation i cotton rat modellen.
Palivizumab serum concentrations of approximately 30 μ g/ ml have been shown to produce a 99% reduction in pulmonary RSV replication in the cotton rat model.